Golden
Clarus Ventures

Clarus Ventures

A venture capital firm from Cambridge, Massachusetts (United States) focusing on healthcare businesses

Clarus Ventures is a venture capital firm from Cambridge, Massachusetts (United States) that focuses on businesses in the healthcare industry. Founded in 2005 by David Field, it funds private equity, early stage ventures and late stage ventures. Founded by a team of experienced professionals, it invests on life science industries such as in biopharmaceuticals and medical technology companies that are into research and development, commercialization, business development and operations management at the global level.

Clarus manages over $2.6 billion, and has put resources into more than 50 private and public businesses in the biotechnology, medical device and diagnostic areas. It utilizes a hands-on approach and use its logical and clinical advancement expertise to invest in new medicines that improve individuals' lives. 





Timeline

2005

Founded

Funded Companies

21 Results
Company
Company
Description
Description
Website
Website
Industry
Industry
Location
Location

A company focused on development of products to treat central nervous system disorders, pain and rare diseases

A company developing products to treat respiratory diseases, including chronic obstructive pulmonary disease

Developing gene therapies to potentially cure rare diseases.

A biotechnology company developing diagnostic tools for cancer

A medical device company developing computer-assisted robotic system to harvest follicular units

A pharmaceutical company engaged in the discovery and development of medicines for inflammatory conditions

A company developing hand-held diagnostic and monitoring devices for screening and management medical conditions

A biopharmaceutical company that develops therapies for age-related macular degeneration and other opthalmic diseases

A biotechnology company developing and commercializing therapeutics for the treatment of respiratory and allergic diseases

A company developing therapeutic proteins and monoclonal antibodies

A company developing antigen for ophthalmology, dermatology and inflammatory diseases

A company developing surgical sealants

A biopharmaceutical company that develops drugs for autoimmune and inflammatory diseases

Oxford Immunotec is a Marlborough, Massachusetts-based company.

A pharmaceutical company focused on developing products for the treatment of glaucoma

A biotechnology company developing antibody fragment technology for opthalmic conditions

Gritstone Oncology is a Emeryville, California-based company.

Cleave Biosciences is a Burlingame, California-based company.

SFJ Pharmaceuticals is a Pleasanton, California-based company.

Associated investment funds

8 Results
Investment Fund
Investment Fund
Total offering (USD)
Total offering (USD)
Total sold (USD)
Total sold (USD)
Location
Location
Date signed
Date signed
880,000,000
789,700,000
May 17, 2017
40,000,000
40,000,000
September 18, 2014
880,000,000
789,700,000
May 17, 2017
100,000,000
100,000,000
August 5, 2014
880,000,000
789,700,000
May 17, 2017
880,000,000
789,700,000
May 17, 2017

People

Name
Role
LinkedIn

Ari Brettman

Principals/Advisor



Barry Gertz

Partners



Dennis Henner

Venture and Operating Partner



Edward Scolnick

Venture and Operating Partner



Emmett Cunningham

Managing Director



Ian Clark

Venture and Operating Partner



Kiran Reddy

Venture and Operating Partner



Kurt C. Wheeler

Managing Director



Lazar Dimitrov

Principals/Advisor



Nicholas Galakatos

Managing Director



Nicholas J. Simon

Managing Director



Paris Panayiotopoulos

Venture and Operating Partner



Robert DeBenedetto

Venture and Operating Partner



Robert W. Liptak

Managing Director



Scott Requadt

Venture and Operating Partner



William Young

Venture and Operating Partner



Further reading

Title
Author
Link
Type
Date









Documentaries, videos and podcasts

Title
Date
Link





Companies

Company
CEO
Location
Products/Services

Annexon Biosciences







Avrobio







Avrobio







Cleave Therapeutics







Flowonix







Forty Seven







Galera Therapeutics







GrayBug







Gritstone Oncology







PATH







References